Highbridge Capital Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-75,200
Closed -$6.39M 101
2019
Q4
$6.39M Sell
75,200
-55,400
-42% -$3.69M 0.71% 39
2019
Q3
$6.53M Buy
+130,600
New +$5.21M 0.95% 33

Other funds holding MDCO

Highbridge Capital Management's MDCO Position: Q3 2015 in Review

Highbridge Capital Management sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 11,649 shares — an estimated $333K sold.

Highbridge Capital Management first reported a position in MDCO in Q2 2014 and held it in 4 quarters. The position peaked at $3.45M in Q1 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • Highbridge Capital Management reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 11,649 Medicines Co shares in Q3 2015, an estimated $333K.
  • Highbridge Capital Management first reported a position in Medicines Co in Q2 2014 and held it in 4 quarters.
  • Highbridge Capital Management's Medicines Co position peaked at $3.45M in Q1 2015.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Highbridge Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.